Imperva (IMPV) Price Target Increased to $55.00 by Analysts at Imperial Capital

Imperva (NASDAQ:IMPV) had its target price increased by research analysts at Imperial Capital from $50.00 to $55.00 in a research report issued on Friday. The brokerage currently has an “outperform” rating on the software maker’s stock. Imperial Capital’s price target points to a potential upside of 18.15% from the company’s previous close.

A number of other research analysts also recently issued reports on the stock. Morgan Stanley boosted their price objective on shares of Imperva from $37.00 to $39.00 and gave the company an “underweight” rating in a research report on Friday. Evercore ISI set a $56.00 price objective on shares of Imperva and gave the company a “buy” rating in a research report on Friday. Piper Jaffray Companies raised shares of Imperva from a “neutral” rating to an “overweight” rating and set a $52.00 price objective on the stock in a research report on Friday. BidaskClub raised shares of Imperva from a “hold” rating to a “buy” rating in a research report on Wednesday. Finally, Zacks Investment Research downgraded shares of Imperva from a “buy” rating to a “hold” rating in a research report on Wednesday, January 10th. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and eleven have issued a buy rating to the company. Imperva presently has a consensus rating of “Hold” and a consensus price target of $52.93.

Imperva (IMPV) traded up $4.50 during trading hours on Friday, reaching $46.55. 2,140,000 shares of the company were exchanged, compared to its average volume of 279,810. Imperva has a 52 week low of $37.17 and a 52 week high of $52.40. The company has a market cap of $1,580.00, a price-to-earnings ratio of 69.48 and a beta of 1.79.

Imperva (NASDAQ:IMPV) last posted its quarterly earnings results on Thursday, February 8th. The software maker reported $0.40 EPS for the quarter, beating the Zacks’ consensus estimate of $0.27 by $0.13. Imperva had a net margin of 3.04% and a negative return on equity of 8.52%. The company had revenue of $91.10 million during the quarter, compared to analyst estimates of $91.11 million. During the same period in the prior year, the business posted $0.32 EPS. The firm’s revenue was up 16.2% compared to the same quarter last year. analysts expect that Imperva will post -0.52 EPS for the current fiscal year.

Large investors have recently added to or reduced their stakes in the company. New York State Common Retirement Fund grew its position in Imperva by 5.3% during the 2nd quarter. New York State Common Retirement Fund now owns 35,800 shares of the software maker’s stock valued at $1,713,000 after purchasing an additional 1,793 shares during the last quarter. Prudential Financial Inc. grew its position in Imperva by 80.7% during the 3rd quarter. Prudential Financial Inc. now owns 54,174 shares of the software maker’s stock valued at $2,351,000 after purchasing an additional 24,190 shares during the last quarter. Wells Fargo & Company MN grew its position in Imperva by 11.9% during the 3rd quarter. Wells Fargo & Company MN now owns 213,953 shares of the software maker’s stock valued at $9,285,000 after purchasing an additional 22,741 shares during the last quarter. American Century Companies Inc. purchased a new stake in Imperva during the 3rd quarter valued at about $6,832,000. Finally, Allianz Asset Management GmbH grew its position in Imperva by 58.1% during the 3rd quarter. Allianz Asset Management GmbH now owns 59,149 shares of the software maker’s stock valued at $2,567,000 after purchasing an additional 21,732 shares during the last quarter. 96.61% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: “Imperva (IMPV) Price Target Increased to $55.00 by Analysts at Imperial Capital” was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/02/09/imperva-impv-price-target-increased-to-55-00-by-analysts-at-imperial-capital.html.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply